Phagos
PrivateLast Round
Series A
Oct 8, 2025
Total Funding Raised
$31.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Phagos operates in Healthcare & Life Sciences and is based in Suresnes. Its latest recorded funding round was a Series A round in October 2025.
Phagos is a biotechnology company that develops AI-driven bacteriophage therapies to combat bacterial diseases, initially focusing on animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phagos Comparables
Compare Phagos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PhageLab | 87% | |
| Proteon Pharmaceuticals | 84% | |
| Sciphage | 76% |
For institutional investors. Book with your work email.
Phagos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 8, 2025 | ||||
| Seed | Sep 27, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Phagos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CapHorn Invest | Series A |
| Hoxton Ventures | Series A, Seed |
| Founders Capital | Series A |
| Acurio Ventures | Series A |
| AgFunder | Series A, Seed |
| Entrepreneurs First | Series A, Seed |
| Citizen Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 61, 81% of headcount.
- Jul 20, 2026
Open roles increased to 30, 41% of headcount.
For institutional investors. Book with your work email.
Phagos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Phagos's valuation, stock price, and market status.
Is Phagos a public or private company?
Phagos is a private company.
What is the current stock price of Phagos?
Phagos is a private company, so its shares have no public market price. Caplight tracks Phagos's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Phagos worth (valuation)?
Valuation information for Phagos is not publicly available.
Can I buy Phagos stock?
Phagos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Phagos's last funding round?
Phagos's most recent funding round was Series A on October 8, 2025.
Who are the main investors in Phagos?
Key investors in Phagos include CapHorn Invest, Hoxton Ventures, Capagro, Demea Sustainable Investment.
Will Phagos IPO soon?
No public IPO plans have been announced for Phagos.
How can I track Phagos secondary market activity?
Caplight tracks bids, offers, and trades in Phagos's shares on secondary markets.